Phenotype MicroArrays for Microbial Cells
Supplied By: Biolog, USA
Rs. 0.00
Phenotype MicroArrays for Microbial Cells Systems & Consumables
Phenotype MicroArray™ Technology enables researchers to characterize cells in up to 1,920 assays and evaluate cell changes under thousands of culture conditions and physiological states in a simple, rapid, efficient and cost-effective manner. By measuring a cell’s response to a genetic or environmental alteration, this integrated system of cellular assays, instrumentation, and bioinformatics software reveals invaluable information to speed insight and discovery and expedite scientific publication. Phenotype MicroArrays (PMs) have broad applicability for genotype-phenotype characterization as well as for determining optimal conditions for cellular growth, sporulation and germination, production of secondary metabolites, or enzymatic activities in cell lines.
The Biolog OmniLog® incubates and monitors 50 microplates, or 1,920 phenotypic assays simultaneously to measure physiological responses in diverse microbial cells.
A Breakthrough in Technology
Phenotype MicroArrays (PMs) represent the third major technology, alongside DNA Microarrays and Proteomic Technologies, that is needed in the genomic era of research and drug development. Just as DNA Microarrays and Proteomic Technologies have made it possible to assay the level of thousands of genes or proteins all at once, Phenotype MicroArrays make it possible to quantitatively measure thousands of cellular phenotypes all at once.
Phenotype MicroArray technology enables researchers to evaluate nearly 2000 phenotypes of a microbial cell in a single experiment. Through comprehensive and precise quantitation of phenotypes, researchers are able to obtain an unbiased perspective of the effect on cells of genetic differences, environmental change, and exposure to drugs and chemicals. You can:
-
Correlate genotypes with phenotypes
-
Determine a cell's metabolic and chemical sensitivity properties
-
Discover new targets for antimicrobial compounds
-
Optimize cell lines and culture conditions in bioprocess development
-
Characterize cell phenotypes for taxonomic or epidemiological studies
Important Applications of PM technology fall into three broad categories:
1. Testing Cell Lines Exposed to Drugs or Other Chemicals
2. Testing Cell Lines with Genetic Differences
3. Direct Testing of Cell Lines
Phenotype MicroArrays for Microbial Cells
Phenotype MicroArray Technology is now available for applications with nearly all important species of bacteria and fungi. Simple protocols are available for testing nearly 2000 cellular phenotypes simultaneously.
Uses with microbial cells
Determine gene functions
-
Compare gene knock-out mutants to wild types
-
Compare naturally-isolated strains with different genetic backgrounds
Identify novel antimicrobial targets by finding genes unique to pathogenic Micro Organisms
-
Find phenotypes present in pathogenic but not in non-pathogenic strains
-
Find phenotypes present in pathogenic microbes but not in host cells (animal or plant)
Test antimicrobial targets and drug leads by comparative phenotyping
-
Determine MOA of drug leads
-
Compare phenotypic changes caused by target gene knockout versus drug addition
Bioprocess improvement
-
Compare and analyze different generations of production strains
-
QC fingerprint production strains
-
Scan 2000 culture conditions simultaneously to optimize the growth medium for product yield
General cell characterization
-
Determine metabolic properties of any microbe
-
Determine drug/chemical sensitivities
Available tests for microbial cells
To view the tests in the PM sets, click on the map links below.
PM-1 to PM-10: Metabolic tests for bacteria and fungi
PM-11 to PM-20: Chemical sensitivity tests for bacteria
PM-21 to PM-25: Chemical sensitivity tests for fungi
Drug Discovery Using PMs
The Drug Discovery Process
PMs can be applied at multiple stages in the drug discovery process, providing researchers with better information to help make better decisions. With PMs the entire process becomes faster and more efficient.
The current drug discovery and development process is long and expensive. Just consider:
-
Only one compound of 10,000 makes it to market
-
It can take upwards of 15 years and $800 million to commercialize a single drug
The challenge for drug companies is three-fold: reduce product development costs… decrease time to market… and increase the probability of success for the most promising leads. Biolog's PM technology can assist with these three challenges — and more.
The genomic revolution has delivered massive amounts of data about life's molecular components, moving the bottleneck in drug discovery downstream by giving drug discovery organizations more qualified targets and leads than ever before. However, there remains a barrier in going from molecular data to understanding what really happens in living cells. PMs provide the needed technology to complement molecular genomics and cross that barrier (see diagram below).
Just as genomics and proteomics have made it possible to measure levels of sounds of genes and proteins all at once, Biolog's new PM technology can quantitatively measure thousands of cellular phenotypes in one analysis. This provides the technological transition over the barrier from molecular to cellular analysis.
Impact on the Drug Discovery Process
Continuing innovations in genomics and analytical technologies have made it particularly difficult for pharmaceutical and biotechnology organizations to determine the optimum approach to employ in the drug discovery process. Biolog has demonstrated that Phenotype MicroArray technology has the ability to deliver significant benefits at multiple stages in the drug discovery process:
Target Identification:
-
Permits direct cellular assay of gene function
-
Complements genetic and molecular methods and extends existing gene expression data
-
Provides analysis of genetic mutations
Lead Validation:
-
Identifies metabolic pathways and may include enzyme specific targeting
Lead Identification:
-
Allows efficient evaluation of drug leads
Lead Optimization:
-
Allows direct observation of a drug's primary and secondary effects at the cellular level
-
Reduces need for expensive, slow animal / plant models
The result of using PM technology? More promising druggable leads and a reduction in failure rates. PMs help drug companies to choose the right drug leads for animal and human testing, saving time and money by lowering the opportunity cost associated with bad decisions.
Brochure on Using PM Technology in Drug Discovery
Click Here to view the document providing an overview of PM technology applied to drug discovery
Mechanism of Action (MOA) of Antimicrobials
Click Here to view the document on Using PM Technology in Antimicrobial MOA Studies
Structure Activity Relationship (SAR) Analysis
Click Here to view a document on Using PM Technology to Guide SAR Studies
Overview
DNA microarrays and proteomic methods made it possible to assay thousands of genes or proteins in a cell at once.
Phenotype MicroArray™ technology is the next step in characterization, making it possible to measure thousands of cellular phenotypes in a single experiment. Through comprehensive and precise quantitation of phenotypes, researchers can obtain an unbiased perspective of the effect on cells of genetic differences, environmental changes, and exposure to drugs or chemicals.
Correlate functional phenotypes with genotypes
Determine a cell strain’s metabolic and chemical sensitivity properties
Elucidate drug susceptibility
Optimize cell lines and bioprocess culture conditions
Characterize cellular phenotypes for taxonomic or epidemiological studies
How it Works
Phenotype MicroArrays are preconfigured 96-well plates containing different classes of chemical compounds. After inoculation with a standardized cell suspension, they are designed to test for the functional presence or absence of thousands of phenotypes in a single experiment.
There are 10 panels designed to interrogate metabolic pathways along with ionic, osmotic and pH effects, and 10 panels to assess the sensitivity to various antimicrobials with different mechanisms of action.
How Phenotype MicroArray Technology Works
Phenotype MicroArrays can be used in two ways. You can monitor cellular respiration by utilizing Biolog’s patented redox dye technology, which amplifies the signal from NADH production. You can also use the MicroArrays to monitor growth without the redox dye present.
Respiration and growth can be simultaneously monitored on Odin™, with and without the redox dye.
An example of how we compare phenotypes between two cell lines is depicted here. Cell line 1 (blue) and cell line 2 (yellow) are grown simultaneously under the same conditions. Our software will overlay the two respiration or growth curves to detect differences. The overlay area is green, allowing a qualitative view of the phenotypic differences between the cell lines.
Checking for Growth with Odin
See what’s happening in two ways.
Odin measures a reporter dye over time at one wavelength to measure NADH production, effectively reporting the rate of metabolic respiration.
It also measures optical density (OD) at a second wavelength to determine how quickly the microbes are dividing. Taken together, you get a full picture of how your microbes grow best over time.
If you’re focused on cell growth, just leave the dye out. Odin automatically compares cell growth and metabolic activity curves to provide you with a clearer picture of how fast or slow your microbes are growing.
Related Products